(E)-4-(1,3-Dioxoisoindolin-2-yl)-2-(1-methyl-1,3-dihydro-2H-benzo[d]imidazol-2-ylidene)-3-oxobutanenitrile

Catalog No. :
ACVAUO588
CAS No. :
868613-98-3
Molecular Formula :
C20H14N4O3
Molecular Weight :
358.36

IUPAC Name:(E)-4-(1,3-dioxoisoindolin-2-yl)-2-(1-methyl-1,3-dihydro-2H-benzo[d]imidazol-2-ylidene)-3-oxobutanenitrile

(E)-4-(1,3-Dioxoisoindolin-2-yl)-2-(1-methyl-1,3-dihydro-2H-benzo[d]imidazol-2-ylidene)-3-oxobutanenitrile structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(E)-4-(1,3-Dioxoisoindolin-2-yl)-2-(1-methyl-1,3-dihydro-2H-benzo[d]imidazol-2-ylidene)-3-oxobutanenitrile
IUPAC Name(E)-4-(1,3-dioxoisoindolin-2-yl)-2-(1-methyl-1,3-dihydro-2H-benzo[d]imidazol-2-ylidene)-3-oxobutanenitrile
Molecular FormulaC20H14N4O3
Molecular Weight358.36
SMILESCN1/C(=C(\C#N)C(=O)CN2C(=O)C3=C(C=CC=C3)C2=O)NC2=CC=CC=C21
InChI KeyJYBLXQVCUKTOJD-NBVRZTHBSA-N
Synonym(E)-4-(1,3-dioxoisoindolin-2-yl)-2-(1-methyl-1,3-dihydro-2H-benzo[d]imidazol-2-ylidene)-3-oxobutanenitrile;2H-Isoindole-2-butanenitrile, α-(1,3-dihydro-1-methyl-2H-benzimidazol-2-ylidene)-1,3-dihydro-β,1,3-trioxo-, (αE)-
CAS No.868613-98-3

Synthetic Route by SureRoute

1. ACVAUO588 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACJDOI249 route compound structure diagram
    ACJDOI2491074-82-4 In Stock
  4. Then
  5. ACVAUO588 route product structure diagram
    ACVAUO588868613-98-3
Inquiry

2. ACVAUO588 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACJDOI249 route compound structure diagram
    ACJDOI2491074-82-4 In Stock
  4. Then
  5. ACVAUO588 route product structure diagram
    ACVAUO588868613-98-3
Inquiry

Comments (0)